+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment



Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment



Rsc Advances 5(92): 75575-75588



More than 230,000 diagnosed cases of invasive breast cancer in women was estimated in 2014 and an expected 40,000 deaths attributed to the aggressive carcinoma. An effective approach to diminish the morbidity and mortality of breast cancer is the development of chemopreventive and chemotherapeutic agents. Nutraceuticals have demonstrated their ability to proficiently halt carcinogenesis. The administration of natural compounds able to effectively serve as chemoprevention and chemotherapeutics without causing harm or adverse effects is imperative. Curcumin derived from the rhizome of Curcuma longa L., is a common spice of India, used for centuries because of its medicinal properties. The main component of curcumin possesses a wide range of biological activities; anti-proliferative, anti-inflammatory, and apoptotic characteristics modulated through the inactivation of pathways such as EGK and Akt/mTOR. In addition, curcumin alters the expression of cytokines, transcription factors, and enzymes involved in cell vitality. The in vivo application of curcumin in breast cancer is hindered by its limited bioavailabiity. The synthesis of curcumin analogues and delivery via nanoparticles has demonstrated enhanced bioavailability of curcumin in the malignancy. This review focuses on recent developments in the use of curcumin, curcumin analogues, and novel delivery systems as a preventive and therapeutic method for breast cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058704949

Download citation: RISBibTeXText

PMID: 27103993

DOI: 10.1039/C5RA14925H


Related references

Recent Advances of Curcumin in the Prevention and Treatment of Renal Fibrosis. Biomed Research International 2017: 2418671-2418671, 2018

Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention. Annals of Oncology 15(12): 1738-1747, 2004

Is mammography indicated for women with defective BRCA genes? Implications of recent scientific advances for the diagnosis, treatment, and prevention of hereditary breast cancer. Medgenmed 2(1): E9-E9, 2000

Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment. Life Sciences 152: 135-144, 2016

Recent advances in the treatment of breast cancer: highlights from the 2010 San Antonio Breast Cancer Symposium. Clinical Advances in Hematology & Oncology 9(5 Suppl 11): 1-16, 2011

Recent advances in the treatment of breast cancer. American Journal of the Medical Sciences 301(5): 337-352, 1991

Recent advances in the treatment of breast cancer. Breast 13(1-Supp-S1): 1-2, 2004

Recent advances in breast cancer treatment. Hong Kong Medical Journal 24(1): 6-8, 2018

Recent Advances in the Treatment of Breast Cancer. Frontiers in Oncology 8: 227-227, 2018

Recent advances in pancreatic cancer: biology, treatment, and prevention. Biochimica et Biophysica Acta 1856(1): 13-27, 2015

Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 16(11/12): 1084-1089, 2000

Recent advances in the hormonal treatment of breast cancer. Current Problems in Surgery 45(1): 13-55, 2008

Recent advances in the medical treatment of breast cancer. F1000research 5: 2786-2786, 2016

Recent Advances in the Neoadjuvant Treatment of Breast Cancer. Journal of Breast Cancer 20(2): 119-131, 2017

Recent advances in hormonal treatment of breast cancer. Onkologie 21(5): 429-433, 1998